## Abstract To improve tumor targeting in a subset of patients, where tumor cells do not express the well‐known tumor antigens widely used in immunotherapy, we have developed a novel biotechnological tool. It is useful for tumors of various origins for the identification of tumor‐associated protein
The surface expression of a tumor-associated antigen on human kappa myeloma cells
✍ Scribed by Heather A. Boux; Robert L. Raison; Karen Z. Walker; Elizabeth Musgrove; Antony Basten
- Publisher
- John Wiley and Sons
- Year
- 1984
- Tongue
- English
- Weight
- 774 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We have isolated and characterized a melanoma tumor-associated antigen (TAA) from the spent culture medium of a melanoma cell line. Its presence has been detected in 72% of different melanoma specimens but not in normal tissues. Because tumor antigens may stimulate or perhaps block immune reactions
The cutaneous lymphocyte-associated antigen (CLA) represents the homing receptor involved in selective migration of memory/effector T cells to the skin. Numerous reports demonstrated distinct CLA expression on Th1 cells. However, T cells isolated from skin lesions and CLA + T cells circulating in pe
Immunization of mice with Moloney murine leukemia virus (MoMuLV) induces the generation of a population of CTL which recognizes a non-viral, tumor-associated antigen FAA) expressed on MuLV-induced tumors. To determine whether this TAA could be used as a pre-leukemic or leukemic cell marker, CTL clon
## Abstract The physico‐chemical nature of Marek's disease tumor‐associated surface antigen (MATSA) on Marek's disease (MD) lymphoblastoid tumor cell line (MDCC‐MSBI‐clo.18) was examined by the cellular enzyme‐linked immunosorbent assay (CELISA) and the sandwich enzyme‐linked immunosorbent assay (E